Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approach-Reference-Cited by-同舟云学术

Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approach

Published:2024-01 Issue: Volume:190 Page:110024
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Gomez-Iturriaga A.,Zaragoza L.,Valverde I.,Perez Azorin F.,Santos-Zorrozua B.,Guerrero J.A.,Couñago F.,Cacicedo J.,Marban M.,Santana S.,Mascarell C.,Novo E.,Fernandez R.,Garcia-Olaverri J.,Urresola A.,Ezquerro A.,Büchser D.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference21 articles.

1. Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results;Hoskin;Radiother Oncol,2021

2. Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

3. Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy;Gomez-Iturriaga;J Contemp Brachytherapy,2014

4. MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?;Gomez-Iturriaga;Clin Transl Radiat Oncol,2020

5. Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion high-dose-rate prostate brachytherapy. Prospective phase II trial;Gomez-Iturriaga;Radiother Oncol,2016